Sanofi ADR (NASDAQ: SNY) kicked off on Friday, up 0.91% from the previous trading day, before settling in for the closing price of $52.87. Over the past 52 weeks, SNY has traded in a range of $45.22-$58.97.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1.99% over the past five years. While this was happening, its average annual earnings per share was recorded 16.04%. With a float of $2.49 billion, this company’s outstanding shares have now reached $2.61 billion.
Let’s look at the performance matrix of the company that is accounted for 87994 employees. In terms of profitability, gross margin is 67.89%, operating margin of 21.72%, and the pretax margin is 15.36%.
Sanofi ADR (SNY) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Sanofi ADR is 0.00%, while institutional ownership is 10.88%.
Sanofi ADR (SNY) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.27% during the next five years compared to 13.78% growth over the previous five years of trading.
Sanofi ADR (NASDAQ: SNY) Trading Performance Indicators
Take a look at Sanofi ADR’s (SNY) current performance indicators. Last quarter, stock had a quick ratio of 0.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.00. Likewise, its price to free cash flow for the trailing twelve months is 22.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.81, a number that is poised to hit 0.84 in the next quarter and is forecasted to reach 4.78 in one year’s time.
Technical Analysis of Sanofi ADR (SNY)
Sanofi ADR (NASDAQ: SNY) saw its 5-day average volume 2.55 million, a negative change from its year-to-date volume of 2.67 million. As of the previous 9 days, the stock’s Stochastic %D was 40.44%. Additionally, its Average True Range was 0.95.
During the past 100 days, Sanofi ADR’s (SNY) raw stochastic average was set at 60.42%, which indicates a significant increase from 58.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.75% in the past 14 days, which was lower than the 22.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $49.66, while its 200-day Moving Average is $51.40. Nevertheless, the first resistance level for the watch stands at $53.58 in the near term. At $53.81, the stock is likely to face the second major resistance level. The third major resistance level sits at $54.01. If the price goes on to break the first support level at $53.14, it is likely to go to the next support level at $52.94. The third support level lies at $52.71 if the price breaches the second support level.
Sanofi ADR (NASDAQ: SNY) Key Stats
The company with the Market Capitalisation of 133.14 billion has total of 2,537,845K Shares Outstanding. Its annual sales at the moment are 47,922 M in contrast with the sum of 6,216 M annual income. Company’s last quarter sales were recorded 11,270 M and last quarter income was 728,620 K.
